South Korea is seeing a growing number of people taking multiple medications, with seniors most affected. About 1.72 million individuals take more than ten medicines due to chronic illnesses. This figure has increased steadily from 1.12 million, showing a 52.5 percent rise in recent years. The majority of these patients, around 80 percent, are aged 65 and above. Health experts warn that polypharmacy cases can raise the risk of adverse reactions and other complications.
Chronic conditions often require ongoing medication, but the use of five or more drugs simultaneously requires careful monitoring. Polypharmacy cases are particularly common among the elderly, who often manage multiple chronic illnesses. The Organization for Economic Cooperation and Development reports that 64.2 percent of Koreans aged 75 and above take five or more medications. This percentage exceeds the OECD average of 50.1 percent, even though it slightly decreased from previous years.
The aging population contributes significantly to rising polypharmacy cases. South Korea now has a substantial proportion of citizens aged 65 and older, making it a superaged society. As the number of seniors rises, the prevalence of multiple medication use increases accordingly. Doctors and health authorities emphasize the importance of monitoring prescriptions and ensuring patients manage their medications safely.
Furthermore, polypharmacy cases can have economic and social implications. Increased hospital visits, higher medical costs, and adverse health outcomes place additional pressure on healthcare systems. Experts recommend better patient education and careful prescription review to reduce risks. South Korea’s healthcare system faces challenges in balancing treatment for chronic illnesses with minimizing polypharmacy complications.
Researchers and policymakers are exploring strategies to address this issue. They suggest integrated healthcare approaches, medication reviews, and digital tools to track prescriptions. Preventive measures and awareness campaigns can help seniors and their families manage medication safely. By taking proactive steps, South Korea aims to reduce polypharmacy cases and protect public health effectively.
Overall, South Korea’s rising polypharmacy cases highlight a critical healthcare challenge. Seniors remain the most affected group, and careful management is crucial. Health authorities are emphasizing monitoring, education, and preventive strategies. By addressing polypharmacy cases effectively, South Korea can improve elderly care and ensure safer treatment for chronic conditions.
